Making complex science mean something.
I'm Staci, a VP Associate Creative Director focused on oncology, rare disease, and high-science brands. I turn complex clinical information into campaigns and content that resonates with HCPs and patients.
across agency tenure
capabilities co-developed
Launched campaigns.
Selected work across oncology and rare disease.
Data vs.
Goliath.
A bold HCP story across two launches.
View SARCLISA project ↗SARCLISA: IMROZ & Subcutaneous Delivery
Multiple myeloma · IMROZ + SC launches · HCP leave-behind
AURYXIA: HCP & patient
Chronic kidney disease · Two-audience campaign launches
OJJAARA: HCP & patient
Myelofibrosis with anemia · Integrated campaign launches
Built with purpose.
Good launch work starts before the first headline. Audience needs, message priorities and creative ideas have to work together.
A clear story for a complex launch.
A look at how audience understanding, content strategy and creative development connect across a new treatment experience.
Explore the approachthe audience
message
experience
The concepts.
Campaign ideas developed for HCP and patient audiences. All work in this section is conceptual.
Day One: According to Kids
Pediatric oncology · Three expressive concept executions
POTELIGEO: I Am the After
CTCL · Patient-led platform · Four executions
ODOMZO: Treatment Shouldn’t Be
Basal cell carcinoma · Portrait-led campaign concept
OJJAARA: Two creative territories
Myelofibrosis with anemia · Five executions
Words with purpose.
HCP messaging, patient education, and clear explanations of complex science.
SARCLISA: Evidence into storytelling
HCP clinical communication · IMROZ & subcutaneous delivery
Good Care Guide: Sickle Cell Conversations
Bluebird bio · Patient education · Long-form writing
Patient Consideration Guide
Gene therapy · Transfusion-dependent beta-thalassemia · Writing
science understandable.GENE THERAPY EDUCATION ↗
GeneHome: Gene therapy education
bluebird bio · Educational website · Long-form science writing
Rethinking how great work gets made.
I'm one of four members of Olixir's AI Power Pod, developing tools that streamline pharmaceutical content creation and review. Of the nine capabilities we've built, four have launched across the agency network.
Time savings are team estimates, not formally measured results. Core claims documentation is estimated to take up to 90% less time; annotation 70% less; prescribing information updates 60% less.
Creative thinker.
Strategic partner.
Always curious.
I'm a VP, Associate Creative Director at Olixir (formerly FCB Health), specializing in oncology, rare disease, and high-science pharmaceutical marketing.
I've helped launch four branded and four unbranded campaigns, led a team of six writers, and contributed to a winning new-business pitch.
My work brings together creative concepts, brand strategy, scientific storytelling, and practical innovation.
Let's talk ↗